Emergent BioSolutions
EBS
#7508
Rank
NZ$0.74 B
Marketcap
NZ$14.35
Share price
2.92%
Change (1 day)
73.66%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): NZ$0.28 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.75 Billion. In 2024 the company made an earning of -NZ$0.13 Billion, an increase over its 2023 earnings that were of -NZ$1.1 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.28 B-337.05%
2024 -NZ$0.13 Billion-88.82%
2023 -NZ$1.1 Billion242.73%
2022 -NZ$0.32 Billion-153.8%
2021 NZ$0.59 B-20.43%
2020 NZ$0.74 B278.02%
2019 NZ$0.19 B27.11%
2018 NZ$0.15 B-27.12%
2017 NZ$0.21 B17.21%
2016 NZ$0.18 B0.45%
2015 NZ$0.18 B73.51%
2014 NZ$0.10 B41.36%
2013 NZ$73.49 M35.2%
2012 NZ$54.36 M0.4%
2011 NZ$54.14 M-56.46%
2010 NZ$0.12 B76.73%
2009 NZ$70.36 M32.94%
2008 NZ$52.93 M-5.62%
2007 NZ$56.08 M
2005 NZ$81.2 M269.89%
2004 NZ$21.95 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.27 B 6,065.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.00 B 13,465.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.77 B 5,886.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$20.97 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.15 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.49 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.64 B 1,201.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel